BlueScope stock enters AGM after FY2026 earnings rebound

Published on 10/07/2026 at 04:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BlueScope stock enters its November 16 AGM after FY2026 underlying EBIT reached AUD 1.273 billion. Analysts set a consensus target of AUD 35.62.

BlueScope, AU000000BSL0, Illustration mit AI erstellt.

BlueScope stock (ISIN AU000000BSL0) enters its November 16, 2026 annual meeting after FY2026 underlying EBIT reached AUD 1.273 billion, according to Motley Fool Australia on September 24, 2026. The result gives the stock a strong earnings base as shareholders approach the next formal company checkpoint.

FY2026 earnings reset the debate

Markets Insider reported on October 2, 2026, that the quarter ending June 30 produced AUD 8.41 billion in revenue and AUD 411.2 million in net profit. Revenue compared with AUD 8.36 billion a year earlier, while the prior-year quarter showed a GAAP net loss of AUD 95.3 million.

The annual picture was similarly sharper. BlueScope's FY2026 underlying EBIT rose to AUD 1.273 billion, supported by stronger US steel production, firmer margins and record Southeast Asian performance, according to Motley Fool Australia.

Analysts price in further upside

The analyst view remains constructive but leaves room for disagreement. According to Markets Insider on October 2, 2026, RBC Capital maintained a Buy rating with an AUD 38.00 price target. The same report placed the consensus at Moderate Buy with an average target of AUD 35.62.

That consensus covers 13 analysts and sets a high target of AUD 40.00 and a low target of AUD 26.00. The spread matters because BlueScope remains exposed to steel prices, regional demand and the durability of North American margins rather than to a single growth market.

AGM puts capital returns in view

BlueScope announced on October 1, 2026, that its hybrid annual general meeting will take place on November 16, 2026, at 10:00 a.m. AEDT. The meeting follows the FY2026 result and gives shareholders a date to assess management's capital allocation and operating priorities.

BlueScope's market capitalization stood at AUD 13.7 billion on October 2, 2026. Its 52-week range was AUD 20.23 to AUD 35.26 as of October 6, 2026, placing the valuation discussion against a broad trading band rather than the earnings result alone.

BlueScope stock carries a broad range

BlueScope stock combines a higher FY2026 earnings base with a consensus target of AUD 35.62 and a scheduled November 16, 2026 AGM. For investors, the central test is whether US-led profitability can remain durable as the company moves beyond its strongest reported year.